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Abstract
In this study, G-coupled estrogen receptor (GPER) was inactivated, by treatment with antagonist (G-15), in testes of C57BL/6
mice: immature (3 weeks old), mature (3 months old) and aged (1.5 years old) (50 μg/kg bw), as well as MA-10 mouse Leydig
cells (10 nM/24 h) alone or in combination with 17β-estradiol or antiestrogen (ICI 182,780). In G-15-treatedmice, overgrowth of
interstitial tissue was found in both mature and aged testes. Depending on age, differences in structure and distribution of various
Leydig cell organelles were observed. Concomitantly, modulation of activity of the mitochondria and tubulin microfibers was
revealed. Diverse and complex GPER regulation at the mRNA level and protein of estrogen signaling molecules (estrogen
receptor α and β; ERα, ERβ and cytochrome P450 aromatase; P450arom) in G-15 Leydig cells was found in relation to age and
the experimental system utilized (in vivo and in vitro). Changes in expression patterns of ERs and P450arom, as well as steroid
secretion, reflected Leydig cell heterogeneity to estrogen regulation throughout male life including cell physiological status.We
show, for the first time, GPER with ERs and P450arom work in tandem to maintain Leydig cell architecture and supervise its
steroidogenic function by estrogen during male life. Full set of estrogen signaling molecules, with involvement of GPER, is
crucial for proper Leydig cell function where each molecule acts in a specific and/or complementary manner. Further under-
standing of the mechanisms bywhich GPER controls Leydig cells with special regard to male age, cell of origin and experimental
system used is critical for predicting and preventing testis steroidogenic disorders based on perturbations in estrogen signaling.
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Introduction
Estrogen is a lipophilic hormone that easily dissolves in lipids,
allowing it to diffuse into the plasma membrane, resulting in
interactions with hydrophobic surfaces of proteins and other
macromolecules. This allows estrogen to associate with recep-
tors that may reside at the cell membrane or in the cytoplasm,
thereby promoting a diverse array of biochemical actions with
different kinetics, including acute (non-genomic) or long-lasting
(genomic) actions. To date, estrogen receptors belonging to the
two distinct receptor families have been described: estrogen
receptors ERα and ERβ that are categorized as steroid hormone
receptors and G-protein-coupled membrane estrogen receptor
(GPER), a member of the G-protein receptor superfamily
(Sharma and Prossnitz 2011; Sandner et al. 2014; Acconcia et
al. 2016). ERs and GPER each participate in estrogen signaling
and likely act in a coordinate manner. Each estrogen receptor
type is considered unique and independent based on genetic,
pharmacological, biological and biochemical evidence (that
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shows distinct physical and functional properties), as well as
displays individual phenotypes in knockout mice (Couse and
Korach 1999; Carreau et al. 2003; Gaudet et al. 2015).
Moreover, these receptors localize to diverse subcellular envi-
ronments, possess a unique binding characteristic and interact
distinctly with selective ligands promoting specific responses.
In males, estrogen is produced by spermatogenic cells (of all
stages) and somatic cells of the testis. Leydig cells are themajor
source of estrogen in the adult testis, while Sertoli cells synthe-
size the majority of estrogen in immature testis (Schulster et al.
2016). The production of estrogens from androgens is
governed by cytochrome P450 aromatase within the endoplas-
mic reticulum of cells, which is expressed also under spatio-
temporal control. P450 aromatase is responsible for catalyzing
the series of reactions that lead to the irreversible conversion of
testosterone and androstenedione into estradiol and estrone,
respectively (Carreau et al. 2003). A proper balance between
androgen and estrogen is fundamental for normal male repro-
ductive development and function in both animals and humans.
In various species including humans, a more significant estro-
gen concentration exists in the male reproductive tract and
semen than in the serum (Hess 2003). Interestingly, in boars,
the intratesticular estradiol level is higher than that in dams in
estrus (Hoffmann et al. 2010). Regulation of testicular cells by
estrogen shows both an inhibitory and a stimulatory influence,
indicating an intricate symphony of dose-dependent and tem-
porally sensitive modulation. In various tissues, estrogen con-
trols growth, differentiation and proliferation/apoptosis migra-
tion of both normal and malignant cells (Barakat et al. 2016;
Acconcia et al. 2016). Estrogen is also a metabolic hormone
and it supervises the integrated physiology of tissues regulating
lipid homeostasis (Shen and Shi 2015).
In the male gonad, inhibition of steroidogenic Leydig cell
regeneration in ethane dimethylsulfonate-treated rats, after
subsequent estradiol exposure, indicates Leydig cells self-
regulate their number via estrogen modulation in a paracrine
fashion of fetal Leydig cell quantity (Abney andMyers 1991).
Furthermore, there is evidence suggesting that estradiol in-
hibits effect of lutropin (LH) on Leydig cells and excess es-
trogen reduces serum testosterone levels (Hess 2003). The
subsequent decrease of testosterone in turn inhibits spermato-
genic function (Atanassova et al. 1999). Studies have con-
firmed that, in the above processes, estrogen signaling via
ERs localized in testicular cells in a species-, age- and physi-
ological status-specific way takes place (for review see Hess
2000; Carreau et al. 2012). Of note, the unique presence of
ERβ in the mitochondria reported since now in cells of human
uterus, ovary, cardiomyocytes, rat primary neurons, human
bone narrow neuroblast (SH-SY5Y) cells, lens epithelial cells,
sperm, human breast cancer (MCF-7) cells, human non-small
cell lung cancer (NSCLC) cells, human adenocarcinomic al-
veolar basal epithelial (A549) cells, human hepatoma
(HepG2) cells, human osteosarcoma (SaOS-2 and 143B) cells
and human retinal ganglion cells (for review see Liao et al.
2015), while ERs splice variants present on the cell membrane
(Irsik et al. 2013) have undiscovered a contribution to this
signaling.
Expression and function of GPER occur independently of
the two nuclear ERs. GPER has a high affinity for estrogens
but only a limited binding capacity with single estrogen-
binding sites (Lazari et al. 2009; Carreau and Hess 2010; Li
et al. 2015). Compared to ERs, its binding affinity for 17β-
estradiol is considerably lower and the association and disso-
ciation rates are very rapid.
Using a Gper-lacZ reporter mouse, extensive expression of
testicular GPER was demonstrated (Isensee et al. 2009). Until
recently, function of GPER in testicular cells was only partially
known. GPER expression was found in a mouse spermatogo-
nia cell line GC-1 (Sirianni et al. 2008), in adult rat pachytene
spermatocytes and round spermatids (Chimento et al. 2010,
2011) highlighting a role for this receptor in spermatogenesis.
Moreover, GPER expression has been currently demonstrated
in Sertoli cells, highlighting their multiple function in seminif-
erous tubule physiology (Lucas et al. 2010, 2011). Sandner et
al. (2014) observed an inverse relationship of GPER
expression and fertility in peritubular cells of monkey and
human. Using qPCR, Fietz et al. (2014, 2016) showed
GPER expression in Leydig cells and Sertoli cells of human
testis. Expression level in Leydig cells was the highest when
compared to Sertoli cells and human breast cancer (MCF-7)
cells. Unfortunately, GPER protein was not analyzed (due to
problem with antibody). Thus, in primate peritubular cells,
GPER mediates estrogen action in both, testis in health and
disease. Our previous studies demonstrated the presence of
GPER in Leydig cells of bank voles with various sex hor-
mones levels; however, receptor expression was not altered
in regard to normal or physiologically decreased intratesticular
estrogen concentration (Zarzycka et al. 2016). The involve-
ment in GPER action second messengers such as protein ki-
nase A and extracellular signals-regulated kinase, as well as
Ca2+, cAMP, cGMP and metalloproteinase 9, was reported
too. Nonetheless, the role of GPER for Leydig cell morpho-
functional status needs further detailed attention.
It has been shown that GPER regulates the proliferative and
apoptotic pathways involved in spermatogenesis (Prossnitz and
Barton 2011) but there are no data on steroidogenic testis func-
tion. No clear developmental or functional defects in the repro-
ductive organs of GPER knockout male mice were reported
(Mårtensson et al. 2009; Otto et al. 2009). On the other hand,
GPER knockouts were moderately obese with larger adipocyte
size indicating lipid homeostasis disturbances. It should be
mentioned here that although there are still controversies on
ERβ knockout mouse fertility, ERα knockouts exhibit various
reproductive organ defects (Krege et al. 1998; Antal et al. 2008;
Lee et al. 2009). In efferent ducts, fluid absorption is altered due
to aquaporin 1 and carbonic anhydrase dysfunction (Hess
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2000). The role of GPER in the male reproductive system is
complex and regulated at multiple levels, thus requiring further
in-depth investigation. This study aims to better understand the
involvement of GPER in Leydig cell function via examination
of the morpho-functional and secretion status of these cells.
Moreover, the interaction between GPER and ERs together
with P450 aromatase is a crucial goal of the present study. To
our knowledge, this is the first in vitro and in vivo study on the
importance of GPER in testicular Leydig cell biology.
Materials and methods
Animals and treatments
Malemice (C57BL/6) 3 weeks old (n = 10), 3 months old (n =
10) and 1.5 years old (n = 10) were obtained from the
Department of Genetics and Evolution, Institute of Zoology
and Biomedical Research, Jagiellonian University, Kraków.
Animals were maintained on 12 h dark-light (250 lx at cages
level) cycle with stable temperature condition (22 °C), relative
humidity of 55 ± 5% and free access to water and standard
pelleted diet (LSM diet, Agropol, Motycz, Poland). Animals
were killed by cervical dislocation. The use of the animals was
approved by the National Commission of Bioethics at the
Jagiellonian University in Krakow, Poland (No. 151/2015).
Mice from various age groups were allotted into experimental
groups (each group including 5 animals); and control (Cont.) and
treated receiving selective GPER receptor antagonist
[(3aS*,4R*,9bR*)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-
3H-cyclopenta[c]quinolone; G-15] (Tocris Bioscience, Bristol,
UK). G-15was dissolved in DMSO and the stock solutions were
kept at − 20 °C. Animals from the experimental groups were
injected subcutaneously with freshly prepared solutions of G-
15 (50 μg/kg bw) in phosphate buffered saline (six doses each
dose injected every other day). Mice from control groups re-
ceived vehicle only. Dose, frequency and time of G-15 adminis-
tration were based on literature data (Dennis et al. 2009; An et al.
2014; Kang et al. 2015) and it was finally selected upon our
preliminary study in mice in vivo (doses range between 5, 50,
100, 150, 200 μg/kg bw). Both testes of each individual of con-
trol andG-15-treatedmicewere surgically removed andwere cut
into small fragments. For histology and immunohistochemistry,
tissue samples were fixed in 10% formalin and embedded in
paraplast. Small pieces of the testicular tissue were immediately
fixed in glutaraldehyde for transmission microscopy analysis or
frozen in a liquid nitrogen and stored at − 80 °C for RNA isola-
tion and determination of steroid hormones.
Histology
For routine histology, hematoxylin-eosin staining was per-
formed. The sections were examined under a Nikon Eclipse
Ni-U microscope (Nikon, Tokyo, Japan). A tubus setting of
1.25, a × 10 ocular and a × 10 objective was used for the
measurements. Detailed morphologic analysis was performed
with the use of NIS-Elements software (Nikon, Tokyo, Japan),
as previously described (Kotula-Balak et al. 2012). The area of
the interstitium occupied by Leydig cells was determined in 40
random fields of vision (which corresponds to 17.7 mm2) for
each animal from the control and treated groups. A mean was
determined for control animals and those treated with G-15.
Cell culture and treatments
The mouse Leydig cell line MA-10 was a generous gift from
Dr. Mario Ascoli (University of Iowa, Iowa City, USA) and
was maintained under standard technique (Ascoli 1981).
Middle passages (p25-p28) of MA-10 cells were used for
the study. The cells were grown in Waymouth’s media
(Gibco, Grand Island, NY) supplemented with 12% horse
serum and 50 mg/l of gentamicin at 37 °C in 5% CO2. Cells
were plated overnight at a density of 1 × 105 cells/ml per well.
Morphological and biochemical properties of MA-10 cells
were regularly checked by microscopic observation, analysis
of proliferation (TC20 Bio-Rad automated cell counter), my-
coplasma detection (MycoFluor™ Mycoplasma Detection
Kit; ThermoFisher Scientific), qRT-PCR analysis of charac-
teristic genes and ELISA measurements of secretion products
according to cell line authentication recommendations of the
Global Bioresource Center (ATCC).
Twenty-four hours before the experiments, the medium was
removed and replaced with a medium without phenol red sup-
plemented with 5% dextran-coated, charcoal-treated FBS (5%
DC-FBS) to exclude estrogenic effects caused by the medium.
Next, cells were treated with selective GPER receptor antago-
nist [(3aS*,4R*,9bR*)-4-(6-bromo-1,3-benzodioxol-5-yl)-
3a,4,5,9b-3H-cyclopenta[c]quinolone; G-15] (Tocris
Bioscience, Bristol, UK) freshly prepared 100 μM stock solu-
tion in dimethyl sulfoxide (DMSO) (Sigma-Aldrich) stored at
− 20 °C. A stock concentration was subsequently dissolved in
Waymouth’s media to final concentration of 10 nM. Cells were
treated with G-15 alone or together with 17β-estradiol (Sigma-
Aldrich; 10 mM) and ER antagonist ICI 182,780 (ICI;
Faslodex, Sigma–Aldrich, St. Louis, MO, USA; 10 μM) fresh-
ly prepared in ethanol, for 24 h. Dose of G-15 was based on
literature data (Dennis et al. 2011; Bertrand et al. 2015;
Carnesecchi et al. 2015; Treen et al. 2016) and it was finally
selected upon our preliminary study (dose range 1, 10,
100 nM). Doses of E2 and ICI were based on our previous
studies (Kotula-Balak et al. 2013; Pardyak et al. 2016; Milon
et al. 2017). Control cells were treated with DMSO or ethanol
or both together (final conc. 0.1%). We performed microscopic
analysis of ultrastructure, as well as mitochondria activity and
cytoskeleton structure of Leydig cells. Culture media were fro-
zen in − 20 °C for steroid hormone level determination.
Cell Tissue Res (2018) 374:389–412 391
Ultrastructure
The fixation procedure described below was based on the
protocols proposed by Russell and Burguet (1977). The mod-
ification developed in our labs had important advantages: it
improved the quality of fixation and enhanced the contrast of
plasma membrane and the organelles. Briefly, Leydig cells in
vitro and dissected testes (control and G-15-treated) were im-
mersed in ice-cold pre-fixative containing 2% formaldehyde
and 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.3.
The tissues were then rinsed and post-fixed in a mixture of 2%
osmium tetroxide and 0.8% potassium ferrocyanide in the
same buffer for 30 min at 4 °C. The material was embedded
in Glycid Ether 100 resin (Serva, Heidelberg, Germany).
Semi-thin sections (0.7 μm thick) were stained with 1%meth-
ylene blue and examined under a Leica DMR (Wetzlar,
Germany) microscope. Prior to embedding, small (3–5 mm)
pieces of testicular tissue were carefully oriented in the mold
to obtain accurate cross-sections of the tubules. Ultrathin sec-
tions (80 nm thick) were contrasted with uranyl acetate and
lead citrate and analyzed with a JEOL 2100 HT (Japan) TEM.
Mitochondrial activity and cytoskeleton structure
Leydig cells (control, G-15, and estradiol-treated) were grown
on coverslips (Ø12 mm; Menzel Gläser, Germany) and used
as live. For mitochondrial activity analysis, MitoTracker™
Orange CMTMRos (Thermo Fisher Scientific) was applied.
Preparation of dye stock solution (1 mM in DMSO) and pre-
formation of staining was prepared based on manufacturer’s
protocol. For tubulin filaments labeling Tubulin Tracker™
Oregon Green ® (Thermo Fisher Scientific), 500 μM in
DMSO according to manufacturer’s protocol was used.
Stained cells were analyzed in a LSM 510 META confocal
systemwith a Zeiss Axiovert 200M invertedmicroscope (Carl
Zeiss GmbH, Jena, Germany). To evaluate the intensity of
fluorescence quantitatively, digital images were obtained and
analyzed using public domain ImageJ software (National
Institutes of Health, Bethesda, Maryland, USA). The intensity
of fluorescence was calculated using the formula described by
Smolen (1990) and expressed as relative fluorescence in arbi-
trary units. Results of 20–30 separate measurements were
expressed as mean ± SD.
RNA isolation, reverse transcription
Total RNA was extracted from control and G-15-treated
mouse testes and Leydig cells using TRIzol® reagent (Life
Technologies, Gaithersburg,MD, USA) according to the man-
ufacturer’s instructions. To remove contaminating DNA and
DNase from RNA preparations, the RNA samples were incu-
bated with reagents from the TURBO DNA-free™ Kit
(Ambion, Austin, TX). The yield and quality of the RNAwere
assessed using a NanoDrop ND2000 spectrophotometer
(Thermo Scientific, Wilmington, DE, USA). Samples with a
260/280 ratio of 1.95 or greater and a 260/230 ratio of 2.0 or
greater were used for analysis. Total cDNA was prepared
using High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Carlsbad, CA, USA) according to the
manufacturer’s instructions.
The purified total RNAwas used to generate total cDNA. A
volume equivalent to 1μg of total RNAwas reverse transcribed
using the High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Carlsbad, CA, USA) according to the
manufacturer’s instructions. Total cDNA was prepared in a
20-μL volume using a random primer, dNTP mix, RNase in-
hibitor and reverse transcriptase (RT). Parallel reactions for
each RNA sample were run in the absence of RT to assess
genomic DNA contamination. RNase-free water was added
in place of the RT product.
Real-time quantitative RT-PCR
Real-time RT-PCR was performed using the StepOne Real-
Time PCR system (Applied Biosystems) and optimized stan-
dard conditions as described previously by Kotula-Balak et al.
(2012, 2013). Based on the gene sequences in the Ensembl
database, primer sets were designed using Primer3 software
(Table 1). Selected primers were synthesized by the Institute
of Biochemistry and Biophysics, Polish Academy of Science
(Warsaw, Poland).
To calculate the amplification efficiency, serial cDNA di-
lution curves were produced for all genes (Pfaffl 2001). A
graph of threshold cycle (Ct) versus log10 relative copy num-
ber of the sample from a dilution series was produced. The
slope of the curve was used to determine the amplification
efficiency: %E = (10–1/slope−1) × 100. All PCR assays
displayed efficiency between 94 and 104%.
Detection of amplification products for GPER, ERα, ERβ
and P450arom and for the reference gene Tubulin a1α
(Tuba1α), was performed with 10 ng cDNA, 0.5 μM primers
and SYBR Green master mix (Applied Biosystems) in a final
volume of 20 μL. Amplifications were performed as follows:
55 °C for 2 min, 94 °C for 10 min, followed by annealing
temperature for 30 s (Table 1) and 45 s 72 °C to determine
the cycle threshold (Ct) for quantitative measurement as de-
scribed previously (Kotula-Balak et al. 2013). To confirm am-
plification specificity, the PCR products from each primer pair
were subjected to melting curve analysis and subsequent aga-
rose gel electrophoresis. In all real-time RT-PCR reactions, a
negative control corresponding to RT reaction without the re-
verse transcriptase enzyme and a blank sample were carried
out (not shown in all figures). All PCR products stained with
Midori Green Stain (Nippon Genetics Europe GmbH, Düren,
Germany) were run on agarose gels. Images were captured
using a Bio-Rad Gel Doc XR System (Bio-Rad Laboratories,
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Hercules, CA, USA). GPER, ERα, ERβ and P450arom
mRNA expressions were normalized to the Tuba1α mRNA
(tested with other references genes: GAPDH and β-actin in a
pilot study) (relative quantification, RQ = 1) with the use of the
2−ΔΔCt method, as previously described by Livak and
Schmittgen (2001).
Three independent experiments were performed, each in
triplicate with tissues prepared from different animals.
Immunohistochemistry, immunocytochemistry
and immunofluorescence
To optimize immunohistochemical staining, testicular sections
both control and G-15-treated were immersed in 10mMcitrate
buffer (pH 6.0) and heated in a microwave oven (2 × 5 min,
700 W). Thereafter, sections were immersed sequentially in
H2O2 (3%; v/v) for 10 min and normal goat serum (5%; v/v)
for 30 min that were used as blocking solutions. Afterwards,
sections were incubated overnight at 4 °C with primary anti-
bodies listed in Table 2. Next, respective biotinylated antibod-
ies (anti-rabbit, anti-goat, and anti-mouse IgGs; 1: 400; Vector,
Burlingame CA, USA) and avidin-biotinylated horseradish
peroxidase complex (ABC/HRP; 1:100; Dako, Glostrup,
Denmark) were applied in succession. Bound antibody was
visualized with 3,3′-diaminobenzidine (DAB) (0.05%; v/v;
Sigma-Aldrich) as a chromogenic substrate. Control sections
included omission of primary antibody and substitution by
irrelevant IgG. Thereafter, sections were washed and were
slightly counterstained with Mayer’s hematoxylin and
mounted using DPX mounting media (Sigma–Aldrich).
Immunocytochemistry or immunofluorescence labeling
was performed on Leydig cells (prepared as previously men-
tioned). Cells were fixed using 4% paraformaldehyde for
5 min or absolute methanol for 7 min followed by acetone
for 4 min both at − 20 °C respectively. Next, only cells for
immunocytochemistry were rinsed in TBS containing 0.1%
Triton X-100. Nonspecific binding sites were blocked with
5% normal goat serum for 30 min. Thereafter, cells were in-
cubated overnight at 4°C in a humidified chamber in the pres-
ence of primary antibodies listed in Table 2. On the next day,
biotinylated antibody goat anti-rabbit (1:400; Vector
Laboratories) or Alexa Fluor 488 goat anti-rabbit antibody
(1:100; Invitrogen, Co., Carlsbad, CA, USA) was applied
for 45 and 60 min, respectively. After each step in these
Table 1 Sequences of forward and reverse primers
Genes Primers (5′–3′) GCCTCT Product size (bp) Annealing temperature (°C) Cycles References
GPER 5′- CTGGACGAGCAGTATTACGATATC - 3′
5′- TGCTGTACATGTTGATCTG - 3′
295 62 35 http://www.ensembl.org
(ENSMUSG00000053647)
P450arom 5′- CCCCTGGACGAAAGTTCTATTG - 3′
5′- CAGCGAAAATCAAATCAGTTGC - 3′
238 62 35 http://www.ensembl.org
(ENSMUSG00000032274)
ERα 5′- GCGCAAGTGTTACGAAGTGG - 3′
5′- AAGCCTGGCACTCTCTTTGC - 3′
375 60 40 http://www.ensembl.org
(ENSMUSG00000019768)
ERβ 5′- TCTGTGTGAAGGCCATGATC - 3′
5′- GCAGATGTTCCATGCCCTTG - 3′
237 60 40 http://www.ensembl.org
(ENSMUSG00000021055)
TUBa1α 5′- CGGAACCAGCTTGGACTTCTTTCCG - 3′
5′- GGAACTGGCTCTGGCTTCACC - 3′
321 60 40 http://www.ensembl.org
(ENSMUST00000134214)
GPER G-coupled membrane estrogen receptor, P450arom cytochrome P450 aromatase, ERα estrogen receptor alpha, ERβ estrogen receptor beta,
TUBa1α tubulin a1α
Table 2 Primary antibodies used for immunocyto-, immunohisto- and immunofluorescence
Antigen Host species of
primary antibodies
Vendor Dilution Host species of secondary antibodies Vendor
GPER Rabbit Abcam
cat.no. ab39742
1:50 (ICC)
1:250 (IHC)
Biotinylated goat anti-rabbit (ICC, IHC) Vector Laboratories
BA-1000
1:100 (IF) Alexa Fluor 488 goat anti-rabbit (IF) Thermo Fisher Scientific
A-11008
P450arom Rabbit Santa Cruz Biotechnology
cat.no. sc-30086
1:100 (ICC)
1:500 (IHC)
Goat anti-rabbit Vector Laboratories
BA-1000
ERα Rabbit Abcam
cat.no. ab75635
1:20 (ICC)
1:100 (IHC)
Goat anti-rabbit Vector Laboratories
BA-1000
ERβ Rabbit Abcam
cat.no. ab3576
1:20 (ICC)
1:50 (IHC)
Goat anti-rabbit Vector Laboratories
BA-1000
GPER G-coupled membrane estrogen receptor, P450arom cytochrome P450 aromatase, ERα estrogen receptor alpha, ERβ estrogen receptor beta
Cell Tissue Res (2018) 374:389–412 393
procedures, cells were carefully rinsed with TBS; the antibod-
ies were also diluted in TBS buffer. The staining for the light
microscopy was developed using ABC/HRP complex for
30 min followed by DAB. Thereafter, cells were washed and
were slightly counterstained with Mayer’s hematoxylin and
mounted using DPX mounting media (Sigma–Aldrich).
Cells were examined with a Leica DMR microscope (Leica
Microsystems, Wetzlar, Germany). Fluorescent staining was
protected from light and cells were mounted with Vectashield
mounting medium (Vector Labs) with 40,6-diamidino-2-
phenylindole (DAPI) or without DAPI and next examined
with an epifluorescence microscope Leica DMR (Leica
Microsystems) equipped with appropriate filters.
The whole procedure was described in detail elsewhere
(Kotula-Balak et al. 2013; Zarzycka et al. 2016; Pawlicki et al.
2017). Experiments were repeated three times.
Radioimmunoassay
Culture media (100 μl) of control and G-15, E2, ICI-treated
Leydig cells were analyzed for progesterone content using the
radioimmunological technique described elsewhere (Abraham
et al. 1971). Progesterone level was determined using
[1,2,6,7-3H]-progesterone (Amersham International plc), spe-
cific activity 96 Ci/mmol, as a tracer and an antibody raised
in a sheep against 11β-hydroxyprogesterone succinyl-bovine
serum albumin (BSA), (a generous gift from Prof. Brian
Cook, University Glasgow, Scotland, UK). Progesterone assay
was validated by demonstrating parallelism between serial di-
lutions of culture media and standard curve. It cross-reacted
with pregnenolone (1.8%), corticosterone (1.5%), 17α-
hydroxyprogesterone (only 0.8%) and testosterone (only
0.12%). Binding of four related steroids such as 20α-
dihydroprogesterone, 20β-dihydroprogesterone, 17α-
hydroxy-20 β-dihydroprogesterone, 17α and 20α-
hydroxyprogesterone and other steroids was below 0.01%.
Coefficients of variation within and between assays were 5.0
and 9.8%, respectively.
To determine and testosterone and estradiol level in testic-
ular homogenates of control and G-15-treated mouse testes,
the radioimmunological technique described elsewhere
(Hotchkiss et al. 1971; Dufau et al. 1972; Pawlicki et al.
2017) was used. Testosterone levels were assessed using
[1,2,6,7-3H]-testosterone (specific activity 110 Ci/mmol;
American Radiolabeled Chemicals, Inc.) as a tracer and rabbit
antibody against testosterone-3-0-CMO:BSA (a gift from Dr.
B. Ričařova, Institute of Radiology, Czech Academy of
Sciences, Prague, Czech Republic). The lower limit of sensi-
tivity was 5 pg. Cross-reaction of this antibody was 18.3%
with dihydrotestosterone, 0.1% with androstenedione and less
than 0.1% with other major testis steroids. Coefficients of var-
iation within and between assays were below 5.0 and 9.7%,
respectively.
Estradiol concentrat ions were measured using
[2,4,6,7-3H]-estradiol (specific activity 81 Ci/mmol:
American Radiolabeled Chemicals, Inc.) as a tracer and rabbit
antibody against estradiol-17-O-carboxymethyloxime: BSA
(a gift from Institute of Pharmacology, Polish Academy of
Sciences, Krakow, Poland). The lower limit of sensitivity of
the assays was 5 pg. Cross-reaction was 1% with keto-
oestradiol-17b, 0.8% with estrone, 0.8% with estriol, 0.01%
with testosterone and less than 0.1% with major ovarian ste-
roids. Coefficients of variation within and between assays
were below 4 and 7.5%, respectively. Assays were validated
by demonstrating parallelism between serial dilutions of cul-
turemedia and standard curve. Coefficients of variation within
and between each assay were 7.6 and 9.8%, respectively. The
recovery of unlabeled steroids was also assessed (never less
than 90%). In addition to monitoring intra-assays and inter-
assays, assay quality control was assessed by control samples
representing low, medium and high concentrations of mea-
sured hormones. Samples (each in triplicate with tissues pre-
pared from different animals) were counted in a scintillation
counter (LKB 1209 RACKBETA LKB; Turku, Finland). The
concentrations of sex steroids were calculated as pg/105 cells.
Statistical analysis
Each variable was tested by using the Shapiro-WilkW test for
normality. Homogeneity of variance was assessed with
Levene’s test. Since the distribution of the variables was nor-
mal and the values were homogeneous in variance, all statis-
tical analyses were performed using one-way analysis of var-
iance (ANOVA) followed by Tukey’s post hoc comparison
test to determine which values differed significantly from con-
trols. The analysis was made using Statistica software
(StatSoft, Tulsa, OK, USA). Data were presented as mean ±
SD. Data were considered statistically significant at p < 0.05.
Results
GPER mRNA level and protein localization in mouse
testes and Leydig cells
Depending on animal age, as well as Leydig cell of origin
(mouse testis or tumor mouse Leydig cell line), differences
in mRNA level were found (Fig. 1a, b). G-15 treatment de-
creased expression of GPER in all treated age groups, with a
significant decrease in mature animals (p < 0.01). In MA-10
Leydig cells treated with G-15, a significant decrease (p <
0.05) was observed as well.
In immature, mature and aged testis sections, membrane-
cytoplasmic localization of GPER was found (Fig. 1c–e). In
MA-10 Leydig cells, GPER was exclusively localized to the
membrane (Fig. 1f).
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Effect of GPER blockage on mouse testis histology
and Leydig cells morphology
G-15 treatment exerted no effect on immature testis while a
slight effect was observed in mature and aged mouse testis
histology (Fig. 2a–f). In control and treated immature males,
the seminiferous tubules filled upwith spermatogenic cells and
small clusters of Leydig cells were observed (Fig. 2a, b). In
control and treated mature males, normal seminiferous tubules
with full spermatogenesis were seen (Fig. 2c, d). In addition,
overgrowth of interstitial tissue was visible when compared to
control (2.21 ± 0.20 vs 1.97 ± 0.14 mm2). In both control and
treated aged animals, a small number of elongated spermatids
in lumens of tubules when compared to mature animals was
observed (Fig. 2e, f and c, d). In treatedmales, when compared
to controls, a slight increase in the interstitial tissue volume
was revealed (2.69 ± 0.05* vs 2.06 ± 0.09 mm2).
Effect of GPER blockage on Leydig cell ultrastructure
Control immature Leydig cells exhibit normal ultrastructure
possessing numerous mitochondria (m) and lipid droplets (ld)
(Fig. 3a, b). After G-15 treatment more lipid droplets were
seen, some surrounded with concentrically located endoplas-
mic reticulum (er) cisternae, thereby suggesting formation of
new lipid droplets (Fig. 3c, d). In control mature Leydig cells,
Fig. 1 GPER mRNA level and protein localization in mouse testes and
Leydig cells. (a–f’). a Representative gel electrophoresis of qualitative
expression, (line N1-negative control without complementary DNA tem-
plate, line N2-negative control without nonreverse transcribed RNA), b
and relative quantification (RQ) of mRNA for GPER in mouse testes;
immature, mature, aged [control and G-15 (50 μg/kg bw)-treated] and
mouse MA-10 Leydig cells [control and G-15 (10 nM)-treated]. RQ is
expressed as means ± SD. Asterisks show significant differences between
control and G-15-treated testes/cells. Values are denoted as *p < 0.05 **p
< 0.01. From each animal, three mRNA samples were analyzed. (c–f’)
Representative microphotographs of cellular localization of GPER in
membrane and cytoplasm of Leydig cells of immature (c), mature (d)
and aged (e) mouse testes and in membrane of mouse MA-10 Leydig
cells (f) (arrows). Immunostaining with DAB and counterstaining with
hematoxylin (c–e). Scale bars represent 15 μm. Staining was performed
on testicular serial sections from at least three animals from each group.
Immunofluorescence with DAPI (f, f’). Scale bars represent 20 μm.
Immunoreaction was performed on Leydig cell cultures in triplicate.
Inserts in (c–e) and (f’)—negative controls—no immunostaining is visi-
ble when the primary antibody is omitted
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lipid droplets were less numerous than in immature cells
(Fig. 4a). Golgi complexes (Gc) and rough endoplasmic retic-
ulum (rer) were frequently seen. In cells treated with G-15,
large mitochondria and numerous lipid droplets were revealed
(Fig. 4b–d). They were localized in relatively large accumula-
tions, indicating cytoskeleton alternations. In control-aged
Leydig cells, the endoplasmic reticulum, mitochondria and lip-
id droplets were normally distributed (Fig. 5a, b). After G-15
treatment, concentrically in structure endoplasmic reticulum
cisternae, probably non-active and degenerating, between
normal-looking mitochondria were revealed (Fig. 5c–e).
Effect of GPER blockage on Leydig cell mitochondrial
activity and cytoskeleton structure
After Leydig cell treatment with each of the mentioned agents,
no morphological alterations were seen (not shown).
Fig. 2 Effect of GPER blockage on mouse testis histology and Leydig
cells morphology (a–f). Representative microphotographs of (a, c, e)
control and (b, d, f) G-15 (50 μg/kg bw)-treated mouse testes. (a, b)
Immature (c, d) mature and (e, f) aged mouse testicular sections.
Hematoxylin-eosin staining. Scale bars represent 15 μm. Staining was
performed on testicular serial sections from at least three animals of each
experimental group. Small clusters of Leydig cells and not active semi-
niferous tubules but with open lumens in a majority of tubules, in both
control and G-15-treated immature males are observed (a, b). Full
spermatogenesis in seminiferous tubules of both control and G-15 mature
males (c, d). Leydig cells in small groups in control (c) but enlarged
interstitial tissue with Leydig cells after exposure to G-15 (d) (arrows)
is visible. Full spermatogenesis but not as active as in mature mice is
observed in aged control and G-15 males (compare number of elongated
spermatids in lumens of tubules c, d and e, f). Leydig cells surrounding
seminiferous tubules and located in groups. Subtle differences in
abundancy of interstitial tissue are seen between control and G-15 aged
males (arrows) (e, f)
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Control Leydig cells were undisturbed, exhibiting high mi-
tochondrial activity (Fig. 6a–i and j) and a normal tubulin
cytoskeleton structure (Fig. 6k–m and n). In cells treated with
G-15, decrease in mitochondrial (p < 0.05) and tubulin activ-
ity was revealed. A marked decrease (p < 0.05) in mitochon-
dria function and tubulin structure (p < 0.05) was found after
treatment with G-15 and E2. After treatment with ICI and E2
alone or in combination (ICI + E2 and ICI + G-15), no signif-
icant changes in the mitochondria and tubulin activity were
revealed (not shown).
Effect of GPER blockage on mRNA expression
of aromatase and estrogen receptors α and β
in mouse testes and Leydig cells in vitro
Electrophoresis revealed PCR-amplified products of the pre-
dicted sizes: 375 bp for ERα, 237 bp for ERβ, 238 bp for
P450arom and 321 bp for tubulin a1α (TUBa1α; reference
gene) in both mouse testes and Leydig cells in vitro (Fig. 7a–
h). Real-time RT-PCR analysis in testes of immature, mature
and aged mice, both control and experimental (G-15-treated),
as well as control and experimental Leydig cells (G-15-, E2-,
ICI-treated alone or in combination), revealed changes in the
expression level of the studied genes (Fig. 7a–h). No marked
differences in TUBa1α levels were revealed either in control
and experimental mouse testes of various age or MA-10
Leydig cells (Fig. 7a, e).
In treated mice of different ages, a similar trend in expres-
sion of estrogen receptors and aromatase was found. In testes
with G-15 treatment, significant increase in expressions of
ERα (p < 0.05; p < 0.01), ERβ (p < 0.001) and P450arom (p
< 0.05; p < 0.01) were observed when compared to their re-
spective controls (Fig. 7a–d).
In in vitro Leydig cells, the same tendency of in vivo ex-
pression of the respective genes was revealed (Fig. 7e–h).
Treatment with E2, ICI, or G-15 alone increased the expres-
sions of ERα (p < 0.05; p < 0.01), ERβ (p < 0.01) and
P450arom (p < 0.05; p < 0.01). Treatment of Leydig cells with
E2, ICI, or G-15 in combination increased expression of both
estrogen receptors and aromatase in comparison to controls;
Fig. 3 Effect of GPER blockage
on Leydig cell ultrastructure.
Representative microphotographs
of Leydig cells of control and G-
15 (50μg/kg bw)-treatedmice. a–
d Immature Leydig cells ultrathin
sections. a Control immature
Leydig cells exhibit normal mor-
phology. In control immature
Leydig cells, numerous mito-
chondria (m) and lipid droplets
(ld) are seen (a). b–d After G-15
treatment in immature Leydig
cells, more lipid droplets (ld) are
observed; some of them are
surrounded with concentrically
located rough reticulum endo-
plasmic (er) cisternae (c; arrow)
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however, the increase was lower (only significant for aroma-
tase p < 0.05) when compared to the individual treatments
with these agents.
Effect of GPER blockage on aromatase and estrogen
receptors localization inmouse testes and Leydig cells
in vitro
When blocked by G-15, immunoexpression of aromatase,
ERα and ERβ in immature, mature, or aged Leydig cells
was altered (Fig. 8a–f). In testes of immature males, no chang-
es in aromatase expression after G-15 treatment were found
when compared to controls (Fig. 8a, b). Immunostaining was
observed in the cytoplasm of all Leydig cells. Increased aro-
matase expression was found in Leydig cells of G-15-treated
mature males while downregulated expression was observed
in control ones (Fig. 8c, d). No difference in expression of
aromatase was noted between control and G-15-treated aged
mice (Fig. 8e, f). Immunoexpression of aromatase in both
groups was of moderate intensity. A slight increase in ERα
expression in the nuclei and in Leydig cell cytoplasm was
noted after G-15 treatment of immature mice (Fig. 9a, b). In
both mature and aged controls and G-15-treated, no change in
ERα expression was observed. Increased expression was
seen in mature males while moderate expression was ob-
served in the nuclei and cytoplasm of aged Leydig cells
(Fig. 9c–f). A slight decrease in ERβ expression was found
in the cytoplasm of immature males in comparison to controls
(Fig. 10a, b). ERβ expression was moderate in controls and
weak in G-15-exposed males and found to be exclusively
localized in the cytoplasm of Leydig cells of mature mice
(Fig. 10c, d). In control aged males, moderate, cytoplasmic
expression of ERβ was found partially localized to the nucle-
us in Leydig cells of males treated with G-15 (Fig. 10e, f). In
negative controls, no positive staining was observed
(Figs. 8a, 9c, and 10e).
Fig. 4 Effect of GPER blockage
on Leydig cell ultrastructure.
Representative microphotographs
of Leydig cells of control and G-
15 (50μg/kg bw)-treatedmice. a–
d Mature Leydig cells ultrathin
sections. In control mature Leydig
cells, lipid droplets (ld) are less
numerous. a, b Mature Leydig
cells exhibit normal morphology.
Golgi complexes (Gc) and rough
ER (rer) are frequently observed
(a, b). c, d In G-15 mature Leydig
cells, large mitochondria (m) and
numerous lipid droplets (ld) lo-
calized in large accumulations are
visible
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Weak tomoderate aromatase immunoreaction was found in
the cytoplasm of all control Leydig cells (Fig. 11a). Increased
aromatase expression was observed after E2 treatment
(Fig. 11b). Following treatment with ICI, weak staining was
observed while after G-15 moderate staining was revealed
(Fig. 11c, d). Combined treatments of ICI with E2, G-15 with
E2 and G-15 with ICI resulted in strong to moderate aroma-
tase expression in a majority of treated cells (Fig. 11e–g).
Strong immunoexpression of ERα was observed in the nuclei
of a majority of control Leydig cells (Fig. 11i). After treatment
with both E2 and ICI, strong nuclear immunostaining was
present in a minority of cells (Fig. 11j, k). G-15 treatment
revealed weak immunostaining in single Leydig cells
(Fig. 11l) but that was not seen in cells treated with ICI to-
gether with E2 or G-15 (Fig. 11m, n). In cells exposed to G-15
with E2, moderate to strong immunostaining was detected in
the cytoplasm (Fig. 11o). Expression of ERβwas moderate in
the nuclei of control Leydig cells (Fig. 11q). E2 treatment
increased ERβ expression that was still visible in the nuclei,
while some cells exhibited cytoplasmic staining (Fig. 11r). In
Fig. 5 Effect of GPER blockage
on Leydig cell ultrastructure.
Representative microphotographs
of Leydig cells of control and G-
15 (50μg/kg bw)-treatedmice. a–
e Aged mouse Leydig cells ultra-
thin sections. Each testicular
sample in the epoxy resin block
was cut for at least three ultrathin
sections that were analyzed. Bars
represent 1 μm. Analysis was
performed on testicular blocks
from at least three animals of each
experimental group. Aged Leydig
cells exhibit normal morphology.
In control aged Leydig cells, nor-
mal number and localization of
endoplasmic reticulum (er), mito-
chondria (m) and lipid droplets
(ld) are seen (a, b). (c–e) Note, in
G-15 aged Leydig cells, the con-
centric structure of endoplasmic
reticulum (er) cisternae (asterisks;
c, e) in between normal-looking
and normal-distributed mitochon-
dria (c, d). (nu) nucleus
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a majority of ICI-treated cells, ERβ staining was weak
(Fig. 11s) while, after treatment with G-15 and ICI, E2 stain-
ing had strong to moderate intensity and was located in the
nuclei of a majority of the cells (Fig. 11t, u). After combined
treatment of G-15 and E2, cytoplasmic staining of ERβ was
observed (Fig. 11v). Moderate to weak nuclear ERβ staining
was detected after G-15 and ICI exposure (Fig. 11w). In neg-
ative controls, no positive staining was observed (Fig. 11h, p,
and x).
Effect of GPER on sex steroid concentration in mouse
testes and secretion by Leydig cells in vitro
The highest androgen concentration was revealed in mature
mice when compared to immature and aged (Fig. 12a). After
treatment with G-15, intratesticular androgen concentration
significantly increased (p < 0.01) in immature mice while it
decreased (p < 0.001) in mature males. In both aged controls
and G-15-treated animals, no changes in androgen concentra-
tions were found. Intratesticular estrogen concentrations were
significantly lower in immature and agedmales in comparison
to those in mature animals (Fig. 12b). Treatment with G-15
did not create marked changes in estrogen levels. In mature
animals, high amounts of estrogen were decreased pro-
nouncedly (p < 0.001) after G-15 exposure.
In Leydig cells, progesterone secretion increased markedly
(p < 0.001) after treatment with E2 alone or in combination
with ICI or G-15 in comparison to controls (Fig. 12c). Neither
ICI, G-15 alone, nor in combination decreased progesterone
secretion when compared to controls.
Discussion
Estrogens are essential for reproductive tract development,
reproductive function and male fertility. Numerous studies
have confirmed these hormones and canonical estrogen
receptors (ERα, ERβ) are present at every stage of gonad
development (Lemmena et al. 1999; Jefferson et al. 2000;
Carreau et al. 2003; Lazari et al. 2009). GPER has been
identified in a variety of human and rodent estrogen target
tissues; thus, its important role in estrogen signaling is cur-
rently highlighted (Chimento et al. 2010; Sandner et al.
2014; Heublein et al. 2012; Zarzycka et al. 2016). GPER
has been suggested to play a role in multiple systems: skel-
etal (under sex-depending manner regulation), immune,
cardiovascular and renal (Prossnitz and Barton 2011).
However, little is known about the role of GPER in both
reproductive and nonproductive cell and tissue biology
from birth to aging. Interestingly, in frogs, early expression
of GPER and aromatase in neuromasts revealed its impor-
tance in lateral line system development (Hamilton et al.
2014). Recent, initial studies by Zhang et al. (2015) dem-
onstrated the involvement of GPER in the proper formation
and growth of mouse gubernaculum. In the reproductive
system, GPER was shown to regulate the proliferative and
apoptotic pathways involved in spermatogenesis through-
out rat reproductive development (Lucas et al. 2014). In
pachytene spermatocytes and round spermatids, GPER ac-
tivated the epidermal growth factor receptor/extracellular
signal-regulated kinases (EGFR/ERK) pathway, thereby in-
ducing the transcriptional modulation of genes controlling
apoptosis and differentiation (Chimento et al. 2014).
In steroidogenic Leydig cells, estrogen supervises overall
growth, development and function of these cells acting both as
a modulator of precursor populations while also inhibiting
steroidogenesis via the effect on LH (Abney 1999).
The action of GPER in estrogen signals requires much
consideration. The results presented here are the first to report
on the influence of GPER on testicular Leydig cell morphol-
ogy and function. Intratesticular estrogen concentrations, as
well as balanced estrogen and androgen concentrations, are
crucial for undisturbed testis function. Any change in the sex
hormone environment leads to alterations in Leydig cell
physiology that affects the action of seminiferous tubules
and vice versa. Our results add to the current knowledge that
individual cells/tissues may modulate estrogen action via
GPER in response to intrinsic factors (e.g., gender, age, genes
activity) or extrinsic modulators of estrogen (e.g., synthetic
estrogens/environmental estrogens) to determine its function
(Filardo and Thomas 2012; Plante et al. 2012). It is not sur-
prising that the highest expression of GPER exists in mature
testis as related to a fully developed and functional reproduc-
tive system. Herein, histological observations in GPER-
blocked testis are in accord with studies in knockout ERβ
where increases in Leydig cells per testis correlate with in-
creased steroidogenic capacity (Gould et al. 2007). Based on
literature data confirming the proliferative nature of estrogen
via both GPER and ER with a contribution of rapid signaling
pathways, this effect can be common and/or shared in a large
Fig. 6 Effect of GPER blockage on Leydig cell mitochondrial activity
and cytoskeleton structure. Representative microphotographs and graphs
of (a–j) mitochondrial activity and (k–n) cytoskeleton structure in
control, G-15- and E2- treated MA-10 Leydig cells. Representative mi-
crophotographs of cellular localization of MitoTracker (a–i) in cytoplasm
of control (a, g), G-15 (b, h) and G-15 with E2 (17β-estradiol) (c, i)-
treated Leydig cells. Immunofluorescence with DAPI (d–f).
Representative microphotographs of cellular localization of
TubulinTracker in cytoplasm of control (k), G-15 (l) and G-15 with E2
(m)-treated Leydig cells. Fluorescence without DAPI. Scale bars repre-
sent 20 μm. Samples of cultured Leydig cells were measured in triplicate.
Quantitative analysis of fluorescence of MitoTracker (j) and
TubulinTracker (n). Histograms of fluorescent intensities expressed as
relative fluorescence (arbitrary units; a.u.). Data are expressed as means
± SD. Asterisks show significant differences between control and G-15
(50 μg/kg bw) - treated mouse testes and control and G-15 (10 nM), E2
(10 nM) - treated cells for 24 h. Values are denoted as * p < 0.05
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amount by one receptor (Lucas et al. 2011; Chimento et al.
2014; Magruder et al. 2014). On the contrary, in knockout
ERα, males’ hypertrophy and loss of Leydig cells with no
disturbances of intratesticular steroid levels were demonstrat-
ed. Our recent study showed overgrowth of Leydig cells after
disturbance of sex hormones milieu, through blockage or
activation of estrogen-related receptors (ERRs) in seasonal
rodent, the bank vole (Pawlicki et al. 2017). In addition, sim-
ilar observations were made in testes of boars treated neona-
tally with antiandrogen (Kotula-Balak et al. 2013). In
consequence, aromatase overexpression in overgrown
Leydig cells was revealed. In patients with germ cell tumors,
elevated levels of chorionic gonadotropin are one possible
cause of Leydig cell hypertrophy and hyperplasia (Zimmerli
and Hedinger 1991). There are multiple other potential mech-
anisms where chemicals might induce hyperplasia primarily
through a disruption in the hypothalamic-pituitary-axis. In
most of these mechanisms, various hormones (e.g., estrogen,
prolactin) produce an elevation in LH levels that excessively
stimulate steroidogenic Leydig cell function (Greaves 2012).
Fig. 7 Effect of GPER blockage on mRNA expression of aromatase and
estrogen receptorsα andβ in mouse testes and Leydig cells in vitro. (a, e)
Representative gel electrophoresis of qualitative expression of
P450aromatase, ERα, ERβ in mouse testes (immature, mature and
aged) (a) and MA-10 Leydig cells (e). (b–d, f–h) Relative level (relative
quantification; RQ) of mRNA for P450aromatase (b), ERα (c), ERβ (d)
in mouse testes (b–d) and MA-10 Leydig cells (f–h), determined using
real-time RT-PCR analysis 2 −ΔCt method. As an intrinsic control, the
tubulin α1a mRNA level was measured in the samples [(a, e) -qualitative
expression]. RQ is expressed as means ± SD. Asterisks show significant
differences between control mice and those treated with G-15 (50 μg/kg
bw) and control MA-10 Leydig cells and treated with G-15 (10 nM), ICI
(ICI 182,780; 10 μM), E2 (17β-estradiol; 10 nM) alone and in combina-
tion for 24 h. Values are denoted as ∗ p < 0.05, ∗∗ p < 0.01 and ∗∗∗ p <
0.001. From each animal, at least three samples were measured. Samples
of cultured Leydig cells were measured in triplicate
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The use of chemical agents that perturb cytoskeletal protein
polarization has shed light on a key role for microfilaments
and microtubules in regulating the uptake and transport of
cholesterol in steroidogenic cells. Sewer and Li (2008) report-
ed that trafficking of the mitochondria is dependent on micro-
tubules, suggesting cytoskeleton function is necessary in ste-
roid hormone production, particularly at steps subsequent to
cholesterol delivery to the mitochondria. Therefore, in ste-
roidogenic cells, proper function of both mitochondria and
cytoskeleton strongly guarantees effective sex steroid produc-
tion. The lack of GPER signaling in mouse testis and Leydig
cells affects the action of the above-mentioned cellular struc-
tures. In addition, estrogen signaling that is partially disturbed
by GPER inactivation modulates the mitochondria and tubu-
lin fiber activity in Leydig cells by estrogen binding to other
estrogen receptors and/or via non-receptor estrogen signaling
molecules. However, due to changes in gene expression of
GPER, ERs and aromatase, such effects are compensational
and/or are directed by one molecule. Of note, robust evidence
indicates the same nuclear ERs are also located at the cell
plasma membrane by palmitoylation and associate with spe-
cific membrane proteins, e.g., caveolin 1 (Pietras and Szego
1977; Razandi et al. 1999; Jakacka et al. 2002). Hence, these
receptors cannot be also excluded from considerations. It is
well-known that different ERα and ERβ isoforms have a very
diverse influence on estrogen signaling and target gene regu-
lation (Chang et al. 2008; Vrtačnik et al. 2014). For example,
some ERβ isoforms lack the ability to bind ligands or
coactivators and certain isoforms affect ERα/ERβ
heterodimerization, leading to silenced ERα signaling. It has
also been reported that ERβ has an inhibitory effect on ERα-
mediated signaling (Murphy 2011). In some instances,
Fig. 8 Effect of GPER blockage
on aromatase and estrogen
receptors localization in mouse
testes. Representative
microphotographs of testicular
sections of control and G-15
(50 μg/kg bw)-treated immature,
mature and aged mice. a–f
Localization of P450aromatase;
dashed lines (a–f) mark the pe-
riphery of seminiferous tubules
(ST). Immunostaining with DAB
and counterstaining with hema-
toxylin. Scale bars represent 15
μm. Immunoreaction was per-
formed on testicular serial sec-
tions from at least three animals of
each experimental group. No
changes in expression of aroma-
tase in testes of immature males
after G-15 treatment in compari-
son to control are seen (arrows)
(a, b). Increase of aromatase ex-
pression is visible in Leydig cells
of mature G-15 males while its
expression is very weak in control
ones (arrows) (c, d). In negative
controls, no positive staining is
seen (inserts a). No differences
between expression of aromatase
are visible in control and G-15
aged mice (e, f). In negative con-
trols, no positive staining is seen
Cell Tissue Res (2018) 374:389–412 403
opposite roles of ERα and ERβ have been revealed by differ-
ences in their expression in various tissues and organs (Girdler
and Brotherick 2000; Hess 2003; Roa et al. 2008; Wang et al.
2016). Based on revealed herein GPER, ERs and aromatase
genes expression changes, we suggest the existence of an
interaction between these genes in mouse Leydig cells of var-
ious age. Of note, any change in GPER function results in
estrogen signaling modulation, leading to changes in intracel-
lular estrogen levels and its action in Leydig cells.
Additionally, ICI affects expression of estrogen signaling
molecules. The antiestrogen ICI 182,780 is similar to estradiol
in its ability to decrease its receptor expression by approxi-
mately 50% (Alarid et al. 1999; Lonard et al. 2000).
Decreased expression of ERα but not ERβ, in rat efferent
ductules after ICI treatment was demonstrated by Oliveira et
al. (2003). Our prior (Hejmej et al. 2011; Kotula-Balak et al.
2013; Zarzycka et al. 2016) and present results confirm that
ER expression is regulated by different mechanisms and is
dependent on tissue type and species studied. Interestingly,
cytoplasmic localization of ERs, coupled with their occasional
absence in Leydig cells, can be linked to a dynamic equilib-
rium between cytoplasm and nucleus. Thus, ERs are not de-
tected at all times in a single subcellular compartment, partic-
ularly when the hormonal milieu is changing (Parikh et al.
1987). Neonatal diethylstilbestrol (DES) treatment also affects
ERα immunoexpression in the male rat reproductive tract
(Rivas et al. 2002).
Estrogen was found to regulate biogenesis and mitochon-
drial function (Klinge 2008). The localization of ERs in
nuclear and ERβ in mitochondrial compartments offers a
potential mechanism for controlling coordinate nuclear and
mitochondrial gene expression and function of the cell.
Fig. 9 Effect of GPER blockage
on aromatase and estrogen
receptors localization in mouse
testes. Representative
microphotographs of testicular
sections of control and G-15
(50 μg/kg bw)-treated immature,
mature and aged mice. (a–f)
Localization of ERα. Expression
of aromatase in both groups is
moderate. Slight increase in ERα
expression in nuclei and partially
in cytoplasm of Leydig cell is
observed in G-15 immature mice
(arrows) (a, b). In both mature
and aged mice (control and G-15-
treated) no changes in expression
of ERα is seen (arrows) (c–f). In
negative controls, no positive
staining is seen (inserts c). The
immunoexpression in cytoplasm
and nuclei of Leydig cells is
strong in mature males while it is
moderate in aged ones (arrows)
(c–f)
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Bopassa et al. (2010) showed involvement of GPER in the
mitochondria permeability transition pore opening in human
cardiovascular cells. In human skin fibroblasts, GPER trans-
mitted estrogen signaling through the ERK1/2 pathway that
regulated fibroblast cytoskeletal reorganization, leading to
changes in cellular shape (Carnesecchi et al. 2015).
Moreover, estrogen- and tamoxifen-induced rearrangement
of the cytoskeleton and adhesion of the breast cancer cells
(MCF-7) (Sapino et al. 1986). In addition, rearrangement of
actin and keratin filaments in the cellular projections and the
formation of a dense network of keratin fibers took place. The
effect was independent of the well-known estrogenic effect
on cell proliferation that correlates with a previous study
where no proliferation of Leydig cells in vitro and rather
volume increase in vivo was observed. Similarly, neither
blocked nor activated ERRs induced Leydig cell proliferation
(Pawlicki et al. 2017). However, both GPER and ERRs
inactivation affected Leydig cell steroidogenic activity by
perturbations in various organelle function.
Estradiol controls the intracellular concentration of both
ERs in a positive feedback manner. This estrogen-dependent
modulation appears to be different for each receptor subtype
since estrogen differentially affects the balance between the
synthesis and breakdown of ERs (Nilsson et al. 2011; Thomas
and Gustafsson 2011). In turn, the presence or absence of a
specific ER subtype, as well as its dynamic temporal varia-
tions in a cell context co-expressing both receptors (i.e., ERα/
ERβ ratio), is pivotal for the appearance of estrogen signaling
and dictates the resulting physiological functions. Of note,
there is evidence for a role for methylation-dependent modu-
lation of ERβ mRNA and the 26S proteasome in regulating
ERβ levels (Pinzone et al. 2004). Estradiol induces ERα
phosphorylation that protects the receptor from degradation,
indicating how the ERα intracellular concentration is required
Fig. 10 Effect of GPER blockage
on aromatase and estrogen
receptors localization in mouse
testes. Representative
microphotographs of testicular
sections of control and G-15
(50 μg/kg bw)-treated immature,
mature and aged mice.
Localization of ERβ (a–f) in tes-
tes of control and G-15-treated
mice, respectively. Slight de-
crease in ERβ expression is ob-
served in cytoplasm of immature
males when compared to control
whose expression is strong
(arrows) (a, b). Moderate in con-
trol mature and weak in G-15
mature males expression of ERβ
is revealed exclusively in cyto-
plasm of Leydig cells (arrows) (c,
d). In control aged males, moder-
ate cytoplasmic expression of
ERβ is seen (arrows) (e) but is
nuclear in a few Leydig cells of
G-15 males (arrows) (f). In nega-
tive controls, no positive staining
is seen (inserts e).
Immunoreaction was performed
on testicular serial sections from
at least three animals of each ex-
perimental group
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for the estradiol-evoked cellular effects (Marques et al. 2014).
We provided a perspective that addresses mRNA expression
changes of estrogen signaling molecules, ERα, ERβ and aro-
matase in mouse Leydig cells with altered GPER activity. In
in vitro Leydig cells, the absence of GPER led to increase of
expression of estrogen signaling molecules. Either interaction
of ERs with ICI or GPER with G-15 in Leydig cells resulted
in comparable and marked estrogen signaling disturbances,
indicating the importance of all receptor types and their inter-
actions for controlling steroidognic cell function in the testis.
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While modulation of ERα and ERβ content is a fundamental
factor in estrogen signaling to maintenance of cell number,
the lack of GPER and/or changes in expression of ERs and
aromatase does not result in cell proliferation or death.
Inhibi t ion of Leydig cell regenerat ion in ethane
dimethylsulfonate-treated mature rats following estradiol ex-
posure indicates that Leydig cells self-regulate their number
via estrogen modulation in a paracrine fashion (Myers and
Abney 1991). Due to these results, involvement of various
estrogen receptors in this phenomenon is suggested.
Additionally, regulation of intracellular ER and aromatase
expression by GPER and vice versa represents a future re-
search direction.
On a new but related point, tamoxifen acting through
GPER is able to upregulate aromatase expression (Catalano
et al. 2014). In the male reproductive system, GPER suppres-
sion of ERα expression and its downstream signaling path-
way was reported (Koong and Watson 2014; Jia et al. 2016).
Studies on GPER intracellular localization revealed its
presence in the plasma membrane, endoplasmic reticulum
and Golgi complex (Chimento et al. 2014). Observed pertur-
bations in these organelles after G-15 treatment are clearly
linked. As data are available concerning estrogen ability to
activate autophagy, including mitophagy (Lui et al. 2016;
Milon et al. 2017), cell context-specific autophagy-based reg-
ulation by GPER cannot be excluded. Until today, detailed
ultrastructure of GPER deficient cells of various organs has
not been performed. The absence of GPER in pancreatic β-
cells did not affect cell morphology, although reduced insulin
secretion from the pancreas was noted (Sharma and Prossnitz
2011). Our results showed that estrogen signaling molecules
control a specific function of various organelles (biogenesis,
distribution, and degeneration) in Leydig cells in an age-
dependent fashion. The coordinated work of lipid droplets,
mitochondria and Golgi apparatus is required for effective
steroidogenesis (Cheng and Kowal 1997; Shen et al. 2016).
We confirmed that the mitochondria are controlled by estro-
gens via ERβ and estrogen-related receptors (ERRs) (Giguère
2002; Liao et al. 2015; Milon et al. 2017) and also by GPER
along with other estrogen signaling molecules. Recent studies
have revealed new proteins associated with lipid droplets,
e.g., GPER, where one of the discovered functions in lipid
metabolism is upregulation of fatty acids synthesis in cancer
cells (Santolla et al. 2012). Data from human embryonic kid-
ney cells (HEK-293) showed that GPER is downregulated
through the trans Golgi-proteasome pathway (Cheng et al.
2011), indicating an important GPER role in Golgi complexes
function. The presence of GPER in endosomes or intracellular
membranes and its capacity to activate plasma membrane re-
ceptors, indicates a critical role of GPER in physiological and
pathophysiological processes. G protein-coupled receptors
(GPCRs) are synthesized in the rough endoplasmic reticulum,
traffic through the Golgi apparatus and are dynamically shut-
tled to and from, the plasma membrane by vesicular transport
[e.g., small GTPases, (Rab-1 and Arf) and chaperone trans-
port proteins (COPI/II)] (Martínez-Alonso et al. 2013).
GPCRs actions via the activation of plasma membrane-
associated enzymes, distinct modes of signal transduction
from endosomal membranes, have also been demonstrated
(for review see Irannejad and von Zastrow 2014). Surface
expression of GPCRs besides extrinsic stimuli can be modu-
lated posttranslationally. Delimitation of GPCRs expression
or receptors desensitization (including complete termination
of receptor signaling, Bdownmodulation^ by 26S proteasome)
affects receptor binding sites and signaling activity (Jean-
Alphonse and Hanyaloglu 2011). A major mechanism by
which GPCRs promote endosome-initiated signaling is by
recruitment of arrestins, which are endocytic adaptors during
receptor desensitization and scaffold for the assembly of
mitogen-activated protein kinase (MAPK) signaling modules
(Shenoy and Lefkowitz 2011).
GPER signaling is a crucial steroidogenesis regulation by
estradiol in rat and human LH-stimulated Leydig cells. The
detrimental effects of estrogen excess after estradiol or GPER
agonist treatment on steroidogenesis were revealed (Hess 2003;
Vaucher et al. 2014). Similarly, in fish gonads, the GPER effect
on steroidogenesis has been shown (Thomas et al. 2006; Pang
Fig. 11 Effect of GPER blockage on localization of aromatase and
estrogen receptors in Leydig cells in vitro . Representative
microphotographs of control MA-10 Leydig cells (a, i, q), E2 (17-β
estradiol; 10 nM) (b, j, r), ICI (ICI 182,780; 10 μM) (c, k, s), G-15
(10 nM) (d, l, t), ICI +E2 (e, m, u), G-15+E2 (f, n, v), G-15+ ICI (g, o,
w)-treated Leydig cells for 24 h. (a–g) Localization of P450aromatase; (i–
o) localization of ERα; localization of ERβ (q–w) in control and G-15-
treated Leydig cells. Immunostaining with DAB and counterstaining with
hematoxylin. Scale bars represent 20 μm. Cultures of Leydig cells from
each experimental group were analyzed in triplicate. Weak to moderate
aromatase immunoreaction is seen in the cytoplasm of control Leydig
cells (arrows) (a). Increase of its expression is visible after E2 treatment
(arrows) (b). After treatment with ICI weak staining while moderate after
G-15 treatment is seen (arrows) (c, d). After combinations of ICI with E2,
G-15with E2 andG-15 with ICI strong tomoderate aromatase expression
in a majority of treated cells is seen (arrows) (e–g). Strong
immunoexpression of ERα is observed in nuclei of control Leydig cells
(arrows) (i). After treatment with both E2 and ICI strong nuclear immu-
nostaining is present in a minority of cells (arrows) (j, k). After G-15
treatment weak immunostaining in single Leydig cells is visible
(arrows), (l) which is not the case in cells treated with ICI together with
E2 or G-15 (arrows) (m, o). In cells treated with G-15 together with E2
moderate to strong cytoplasmic immunostaining is seen (arrow) (n).
Moderate expression of ERβ in a majority of nuclei of control Leydig
cells is observed (arrows) (q). Increased after E2 treatment immunostain-
ing of ERβ is visible in nuclei of a majority of cells (r). In a few cells
staining is cytoplasmic (short arrow) (r). In a majority of ICI - treated cells
the ERβ staining is weak (arrows) (s) while after exposure to G-15 and
ICI with E2 staining is of strong to moderate intensity and located in
nuclei of a majority of cells (arrows) (t, u). After treatment with G-15
and E2 in combination mainly cytoplasmic staining for ERβ is observed
(arrows) (v). Moderate to weak nuclear ERβ staining is visible after G-15
and ICI exposure (arrows) (w). In negative controls, no positive staining
is seen (inserts h, p, x)
Cell Tissue Res (2018) 374:389–412 407
and Thomas 2010). Therefore, decreased estrogen concentra-
tion in mice without GPER (and modulated expression of ERs
and aromatase genes) confirmed a full set of estrogen signaling
molecule control of Leydig cell steroidogenic function at the
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ultrastructure (organelle activity) and molecular (hormone pro-
duction and secreting ability) levels.
Conclusion
The GPER provides a new basis for understanding the roles
of estrogen and estrogen signaling molecules in the regula-
tion of Leydig cells function. The data presented here re-
vealed that GPER has a regulatory effect on estrogen sig-
naling, as well as estrogen concentration and secretion in
mouse Leydig cells (dependent of male age and putative
engagement of various organelle) via its partnership with
ERs and aromatase. Thus, the generation of a triple KO
murine model (aromatase, ER, and GPER) could be an
important contribution to further understand the mecha-
nisms of estrogen signaling in Leydig cells.
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